skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 next page
Refinado por: assunto: Prognosis remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

Tefferi, A ; Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Finke, C ; Mannarelli, C ; Belachew, A A ; Pancrazzi, A ; Wassie, E A ; Ketterling, R P ; Hanson, C A ; Pardanani, A ; Vannucchi, A M

Leukemia, 2014-07, Vol.28 (7), p.1494-1500 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Classification and Personalized Prognosis in Myeloproliferative Neoplasms

Grinfeld, Jacob ; Nangalia, Jyoti ; Baxter, E. Joanna ; Wedge, David C ; Angelopoulos, Nicos ; Cantrill, Robert ; Godfrey, Anna L ; Papaemmanuil, Elli ; Gundem, Gunes ; MacLean, Cathy ; Cook, Julia ; O’Neil, Laura ; O’Meara, Sarah ; Teague, Jon W ; Butler, Adam P ; Massie, Charlie E ; Williams, Nicholas ; Nice, Francesca L ; Andersen, Christen L ; Hasselbalch, Hans C ; Guglielmelli, Paola ; McMullin, Mary F ; Vannucchi, Alessandro M ; Harrison, Claire N ; Gerstung, Moritz ; Green, Anthony R ; Campbell, Peter J

The New England journal of medicine, 2018-10, Vol.379 (15), p.1416-1430 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
3
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

Tefferi, A ; Rumi, E ; Finazzi, G ; Gisslinger, H ; Vannucchi, A M ; Rodeghiero, F ; Randi, M L ; Vaidya, R ; Cazzola, M ; Rambaldi, A ; Gisslinger, B ; Pieri, L ; Ruggeri, M ; Bertozzi, I ; Sulai, N H ; Casetti, I ; Carobbio, A ; Jeryczynski, G ; Larson, D R ; Müllauer, L ; Pardanani, A ; Thiele, J ; Passamonti, F ; Barbui, T

Leukemia, 2013-09, Vol.27 (9), p.1874-1881 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

TEFFERI, A ; LASHO, T. L ; MAI, M ; MCCLURE, R. F ; GILLILAND, D. G ; LEVINE, R. L ; PARDANANI, A ; VANNUCCHI, A. M ; ABDEL-WAHAB, O ; GUGLIELMELLI, P ; PATEL, J ; CARAMAZZA, D ; PIERI, L ; FINKE, C. M ; KILPIVAARA, O ; WADLEIGH, M

Leukemia, 2010-07, Vol.24 (7), p.1302-1309 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Score, J ; Mannarelli, C ; Pancrazzi, A ; Biamonte, F ; Pardanani, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Fanelli, T ; Pietra, D ; Rumi, E ; Finke, C ; Gangat, N ; Ketterling, R P ; Knudson, R A ; Hanson, C A ; Bosi, A ; Pereira, A ; Manfredini, R ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Vannucchi, A M ; Tefferi, A

Leukemia, 2014-09, Vol.28 (9), p.1804-1810 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Mutations and prognosis in primary myelofibrosis
Mutations and prognosis in primary myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutations and prognosis in primary myelofibrosis

Vannucchi, A M ; Lasho, T L ; Guglielmelli, P ; Biamonte, F ; Pardanani, A ; Pereira, A ; Finke, C ; Score, J ; Gangat, N ; Mannarelli, C ; Ketterling, R P ; Rotunno, G ; Knudson, R A ; Susini, M C ; Laborde, R R ; Spolverini, A ; Pancrazzi, A ; Pieri, L ; Manfredini, R ; Tagliafico, E ; Zini, R ; Jones, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Pietra, D ; Rumi, E ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Tefferi, A

Leukemia, 2013-09, Vol.27 (9), p.1861-1869 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis

Guglielmelli, P ; Rotunno, G ; Fanelli, T ; Pacilli, A ; Brogi, G ; Calabresi, L ; Pancrazzi, A ; Vannucchi, A M

Blood cancer journal (New York), 2015-10, Vol.5 (10), p.e360-e360 [Periódico revisado por pares]

United States: Springer Nature B.V

Texto completo disponível

Citações Citado por
8
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients

PARDANANI, A ; GUGLIELMELLI, P ; LASHO, T. L ; PANCRAZZI, A ; FINKE, C. M ; VANNUCCHI, A. M ; TEFFERI, A

Leukemia, 2011-12, Vol.25 (12), p.1834-1839 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

Barosi, G ; Tefferi, A ; Besses, C ; Birgegard, G ; Cervantes, F ; Finazzi, G ; Gisslinger, H ; Griesshammer, M ; Harrison, C ; Hehlmann, R ; Hermouet, S ; Kiladjian, J-J ; Kröger, N ; Mesa, R ; Mc Mullin, M F ; Pardanani, A ; Passamonti, F ; Samuelsson, J ; Vannucchi, A M ; Reiter, A ; Silver, R T ; Verstovsek, S ; Tognoni, G ; Barbui, T

Leukemia, 2015-01, Vol.29 (1), p.20-26 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Elevated C-reactive protein is associated with shortened leukemia-free survival in patients with myelofibrosis

Barbui, T ; Carobbio, A ; Finazzi, G ; Guglielmelli, P ; Salmoiraghi, S ; Rosti, V ; Rambaldi, A ; Vannucchi, A M ; Barosi, G

Leukemia, 2013-10, Vol.27 (10), p.2084-2086 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2006  (3)
  2. 2006Até2009  (4)
  3. 2010Até2012  (6)
  4. 2013Até2016  (14)
  5. Após 2016  (2)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (27)
  2. Japonês  (8)
  3. Alemão  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.